Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
As demand for weight-loss drugs rises, states grapple with Medicaid coverage In January, the National Association of Medicaid Directors told the federal Centers for Medicare & Medicaid Services that state Medicaid departments had significant concerns over the fiscal impacts of the Biden proposal to require coverage of GLP-1s, and strongly recommend that CMS maintain the current state option to cover or not cover anti-obesity medications. But others say covering the drugs will yield long-term savings
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis
Researchers found that patients who achieved the greatest reductions in body weight after starting GLP-1-based medications had substantially lower risks of conditions including obstructive sleep apnea, chronic kidney disease, osteoarthritis, and heart failure
Some users report they feel immediate effects of a lipo injection after it is administered
